Medicare Now Covers Genetic Tests for Targeting Depression Drugs

An oral swab test that gives doctors an easy-to-read report to help guide decisions about prescribing depression medications is now available to 50 million Americans on Medicare.

More Medicare Now Covers Genetic Tests for Targeting Depression Drugs